Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Wed, 30.04.2025
Galaxy Entertainment Group
EQS Newswire / 30/04/2025 / 05:30 CET/CEST
MACAU SAR - Media OutReach Newswire - 30 April 2025 - In celebration of the 30th anniversary of diplomatic relations between China and Monaco, Galaxy Macau™ proudly presents the "Galaxy Music Gala: A Musical Journey from Monaco to Macau". On May 21. This prestigious evening of classical music celebrat [ … ]
Wed, 30.04.2025
Backbase
EQS Newswire / 30/04/2025 / 05:00 CET/CEST
Industry pioneer redefines what a banking platform is in the era of AI, and delivers both the technology and talent to drive remarkable growthAMSTERDAM, NETHERLANDS - Media OutReach Newswire - 30 April 2025 - Today, Backbase announces a major industry shift: the launch of the world's first AI-powered [ … ]
Wed, 30.04.2025
AIA Singapore
EQS Newswire / 30/04/2025 / 02:15 CET/CEST
Aligned to the theme of "Building Our Singapore Together", the efforts aim to make a meaningful impact on Singaporeans of all generationsSINGAPORE - Media OutReach Newswire - 30 April 2025 - AIA Singapore today announced a year-long line-up of initiatives designed to connect with Singaporeans across a [ … ]
Wed, 30.04.2025
Goodme
EQS Newswire / 30/04/2025 / 02:00 CET/CEST
TOKYO, JAPAN - Media OutReach Newswire - 30 April 2025 - With the visa-free transit policy for Japanese tourists implemented by China at the end of 2024, as well as its high-quality yet low-cost consumption and geographical advantages, an increasing number of Japanese tourists have been attracted to C [ … ]
Tue, 29.04.2025
ABIVAX
Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis
The Phase 3 ABTECT trials (Studies 105 and 106) evaluating obefazimod in patients with moderately to severely active ulcerative colitis successfully enrolled 1,275 participants, exceeding the target enrollment [ … ]
Tue, 29.04.2025
aap Implantate AG
aap Implantate AG ("Company") announces that the auditor will no longer complete the audit of the annual and consolidated financial statements for the financial year 2024 in April. As a result, the Company will not be able to publish the annual and consolidated financial statements for 2024 within the statutory deadline of 30 April 2025. The compan [ … ]
Tue, 29.04.2025
Gateway Real Estate AG
Gateway Real Estate AG is postponing publication of the audited consolidated financial statements 2024
Berlin, April 29, 2025. Gateway Real Estate AG („Company“ – WKN A0JJTG / ISIN DE000A0JJTG7) decided today to postpone the publication of the audited consolidated financial statements for 2024. The reason for this is in particular that the company [ … ]
Tue, 29.04.2025
Hypoport SE
Inside information pursuant to article 17 of the Market Abuse Regulation (MAR)
Hypoport SE: Significant Increase in Revenue and EBIT in Q1 2025
Berlin, April 29, 2025: In today's board meeting, the preliminary business figures of the Hypoport Group for the first quarter of 2025 were evaluated.
Based on this, the Hypoport board expects [ … ]
Tue, 29.04.2025
CANCOM SE
CANCOM SE: Q1 2025 results significantly below previous year's figure as expected; forecast for the full year 2025 confirmed
Munich, 29 April 2025 - As expected by the Executive Board, CANCOM SE's business in the first quarter of 2025 was characterised by the continuing challenging market conditions. As expected, Group revenues for the first quart [ … ]
Tue, 29.04.2025
EuroTeleSites AG
+5.9% revenue growth YoY resulted in mEUR 67.7 revenues
EBITDA in Q1 at mEUR 59.6 with EBITDA margin at 88.0%
EBITDAaL in Q1 at mEUR 40.2 with EBITDAaL margin at 59.5%
Rollout of 36 new sites in Q1 leads to 13,662 total sites
Onboarding of 24 third-party tenants on existing and new sites in Q1
CAPEX at mEUR 12.3, with mandatory upgrades still [ … ]